MapLight Therapeutics (MPLT) Times Interest Earned (2024 - 2025)

MapLight Therapeutics (MPLT) reported Times Interest Earned of -$277.92 for Q4 2025, down 466.06% on a YoY basis from $75.92 in Q4 2024, and down 3535.29% sequentially from -$7.65 in Q3 2025.

MapLight Therapeutics (MPLT) Times Interest Earned (2024 - 2025) Analysis & Trends

MapLight Therapeutics (MPLT) has 2 years of Times Interest Earned data on file, last reported at -$277.92 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 658.42
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 7.60
4 NuCana 279.75 Bn 279.75 Bn - -0.22
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.72
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -0.38
10 MapLight Therapeutics 305.82 Mn 305.82 Mn - -277.92

Historic Data

Download Data
DateValue
Dec 31, 2025 -277.92
Sep 30, 2025 -7.65
Dec 31, 2024 75.92
Sep 30, 2024 -69.65